ABCL logo

AbCellera Biologics Inc. (ABCL) Free cash flow

annual FCF:

-$186.95M-$65.57M(-54.02%)
December 31, 2024

Summary

  • As of today (August 29, 2025), ABCL annual free cash flow is -$186.95 million, with the most recent change of -$65.57 million (-54.02%) on December 31, 2024.
  • During the last 3 years, ABCL annual FCF has fallen by -$373.08 million (-200.44%).
  • ABCL annual FCF is now -191.33% below its all-time high of $204.70 million, reached on December 31, 2022.

Performance

ABCL Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

quarterly FCF:

-$47.01M-$24.82M(-111.85%)
June 1, 2025

Summary

  • As of today (August 29, 2025), ABCL quarterly free cash flow is -$47.01 million, with the most recent change of -$24.82 million (-111.85%) on June 1, 2025.
  • Over the past year, ABCL quarterly FCF has increased by +$2.25 million (+4.56%).
  • ABCL quarterly FCF is now -119.56% below its all-time high of $240.37 million, reached on June 30, 2022.

Performance

ABCL quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

TTM FCF:

-$137.24M+$2.25M(+1.61%)
June 1, 2025

Summary

  • As of today (August 29, 2025), ABCL TTM free cash flow is -$137.24 million, with the most recent change of +$2.25 million (+1.61%) on June 1, 2025.
  • Over the past year, ABCL TTM FCF has increased by +$31.57 million (+18.70%).
  • ABCL TTM FCF is now -148.86% below its all-time high of $280.91 million, reached on June 30, 2022.

Performance

ABCL TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

ABCL Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-54.0%+4.6%+18.7%
3 y3 years-200.4%-119.6%-148.9%
5 y5 years-10000.0%-311.1%-961.7%

ABCL Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-191.3%at low-119.6%+67.2%-148.9%+30.1%
5 y5-year-191.3%at low-119.6%+67.2%-148.9%+30.1%
alltimeall time-191.3%at low-119.6%+67.2%-148.9%+30.1%

ABCL Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$47.01M(+111.9%)
-$137.24M(-1.6%)
Mar 2025
-
-$22.19M(+8.5%)
-$139.49M(-23.8%)
Dec 2024
-$186.95M(+54.0%)
-$20.46M(-57.0%)
-$183.14M(-6.2%)
Sep 2024
-
-$47.58M(-3.4%)
-$195.26M(+15.7%)
Jun 2024
-
-$49.26M(-25.2%)
-$168.81M(+32.8%)
Mar 2024
-
-$65.85M(+102.1%)
-$127.09M(+5.7%)
Dec 2023
-$121.38M(-159.3%)
-$32.58M(+54.2%)
-$120.29M(+62.0%)
Sep 2023
-
-$21.13M(+180.5%)
-$74.24M(-62.2%)
Jun 2023
-
-$7.53M(-87.2%)
-$196.38M(-481.2%)
Mar 2023
-
-$59.05M(-538.3%)
$51.52M(-73.8%)
Dec 2022
$204.70M
$13.47M(-109.4%)
$196.29M(+25.3%)
Sep 2022
-
-$143.28M(-159.6%)
$156.61M(-44.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
$240.37M(+180.4%)
$280.91M(+70.3%)
Mar 2022
-
$85.72M(-427.1%)
$164.94M(-10.9%)
Dec 2021
$186.13M(+2221.7%)
-$26.21M(+38.1%)
$185.12M(-12.4%)
Sep 2021
-
-$18.98M(-115.3%)
$211.23M(-5.2%)
Jun 2021
-
$124.40M(+17.5%)
$222.86M(+84.6%)
Mar 2021
-
$105.90M(<-9900.0%)
$120.73M(+1322.9%)
Dec 2020
$8.02M(-715.3%)
-$101.70K(-98.6%)
$8.48M(-1.2%)
Sep 2020
-
-$7.34M(-133.0%)
$8.59M(-46.1%)
Jun 2020
-
$22.27M(-450.9%)
$15.93M(-350.9%)
Mar 2020
-
-$6.35M
-$6.35M
Dec 2019
-$1.30M(-25.2%)
-
-
Dec 2018
-$1.74M
-
-

FAQ

  • What is AbCellera Biologics Inc. annual free cash flow?
  • What is the all time high annual FCF for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual FCF year-on-year change?
  • What is AbCellera Biologics Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly FCF year-on-year change?
  • What is AbCellera Biologics Inc. TTM free cash flow?
  • What is the all time high TTM FCF for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. TTM FCF year-on-year change?

What is AbCellera Biologics Inc. annual free cash flow?

The current annual FCF of ABCL is -$186.95M

What is the all time high annual FCF for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual free cash flow is $204.70M

What is AbCellera Biologics Inc. annual FCF year-on-year change?

Over the past year, ABCL annual free cash flow has changed by -$65.57M (-54.02%)

What is AbCellera Biologics Inc. quarterly free cash flow?

The current quarterly FCF of ABCL is -$47.01M

What is the all time high quarterly FCF for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly free cash flow is $240.37M

What is AbCellera Biologics Inc. quarterly FCF year-on-year change?

Over the past year, ABCL quarterly free cash flow has changed by +$2.25M (+4.56%)

What is AbCellera Biologics Inc. TTM free cash flow?

The current TTM FCF of ABCL is -$137.24M

What is the all time high TTM FCF for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high TTM free cash flow is $280.91M

What is AbCellera Biologics Inc. TTM FCF year-on-year change?

Over the past year, ABCL TTM free cash flow has changed by +$31.57M (+18.70%)
On this page